CA Stock MarketDetailed Quotes

WLLW Willow Biosciences Inc

Watchlist
  • 0.100
  • 0.0000.00%
15min DelayTrading Aug 30 09:51 ET
14.42MMarket Cap-1666P/E (TTM)

Willow Biosciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
80.10%-733K
54.20%-1.75M
21.22%-10.92M
74.16%-1.07M
28.15%-2.35M
-8.10%-3.68M
-24.93%-3.82M
23.95%-13.86M
18.59%-4.13M
22.43%-3.27M
Net income from continuing operations
53.19%-1.69M
50.57%-2.36M
12.05%-13.03M
48.51%-2.42M
44.03%-2.23M
-14.38%-3.6M
-60.66%-4.77M
-141.27%-14.81M
9.41%-4.71M
-203.83%-3.99M
Operating gains losses
----
-575.00%-135K
99.39%-23K
--0
96.71%-5K
100.12%2K
98.94%-20K
77.52%-3.76M
96.25%-45K
98.44%-152K
Depreciation and amortization
-20.50%353K
-22.12%352K
-30.80%1.83M
-22.75%377K
20.26%558K
-45.52%444K
-48.58%452K
-17.11%2.65M
-40.63%488K
-45.02%464K
Asset impairment expenditure
--0
--0
--19K
--0
--0
--0
--19K
--0
--0
--0
Remuneration paid in stock
-32.05%106K
-70.08%158K
-71.25%420K
-59.20%82K
-194.79%-346K
-61.58%156K
7.98%528K
-14.21%1.46M
-61.93%201K
-26.41%365K
Deferred tax
----
----
---15K
----
----
----
----
--0
----
----
Other non cashItems
95.00%39K
223.08%42K
-82.24%84K
828.57%65K
-109.92%-13K
-93.90%20K
85.71%13K
1,651.85%473K
-12.50%7K
1,771.43%131K
Change In working capital
165.05%456K
568.29%192K
-260.47%-207K
1,330.43%849K
-234.04%-314K
-456.35%-701K
-109.81%-41K
140.82%129K
-215.00%-69K
-129.65%-94K
-Change in receivables
--135K
110.59%18K
----
----
----
----
-2,733.33%-170K
----
----
----
-Change in inventory
--92K
-97.06%1K
----
----
----
----
88.89%34K
----
----
----
-Change in prepaid assets
--57K
-20.25%256K
----
----
----
----
9.93%321K
----
----
----
-Change in payables and accrued expense
--170K
29.20%-160K
----
----
----
----
-22,700.00%-226K
----
----
----
-Change in other working capital
--2K
--77K
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
80.10%-733K
54.20%-1.75M
21.22%-10.92M
74.16%-1.07M
28.15%-2.35M
-8.10%-3.68M
-24.93%-3.82M
23.95%-13.86M
18.59%-4.13M
22.43%-3.27M
Investing cash flow
Cash flow from continuing investing activities
0
-96.12%135K
176.10%3.47M
100.17%6K
-110.45%-14K
99.89%-1K
1,159.76%3.48M
-171.98%-4.55M
-1,033.11%-3.46M
120.68%134K
Capital expenditure reported
----
--0
9.24%-619K
-123.20%-58K
83.96%-30K
----
---524K
61.38%-682K
167.75%250K
66.67%-187K
Net PPE purchase and sale
--0
--135K
-94.31%7K
-91.25%7K
--0
---7K
--0
3.36%123K
--80K
--43K
Net investment purchase and sale
--0
--0
199.50%4M
99.50%-20K
--21K
--1K
--4M
---4.02M
---4.02M
--0
Net other investing changes
----
----
196.15%77K
----
-101.80%-5K
101.34%5K
----
196.30%26K
265.63%234K
419.54%278K
Cash from discontinued investing activities
Investing cash flow
--0
-96.12%135K
176.10%3.47M
100.17%6K
-110.45%-14K
99.89%-1K
1,159.76%3.48M
-171.98%-4.55M
-1,033.11%-3.46M
120.68%134K
Financing cash flow
Cash flow from continuing financing activities
216.89%346K
140.80%71K
56.02%-318K
238.34%267K
33.53%-115K
-67.23%-296K
3.33%-174K
-102.12%-723K
19.25%-193K
-8.81%-173K
Net issuance payments of debt
13.79%-200K
-13.79%-198K
70.68%-212K
413.92%609K
-139.88%-415K
-33.33%-232K
4.40%-174K
-13.50%-723K
-18.29%-194K
-4.85%-173K
Net common stock issuance
--0
--270K
----
----
----
--0
--0
----
----
----
Net other financing activities
953.13%546K
---1K
---106K
---342K
--300K
-2,033.33%-64K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
216.89%346K
140.80%71K
56.02%-318K
238.34%267K
33.53%-115K
-67.23%-296K
3.33%-174K
-102.12%-723K
19.25%-193K
-8.81%-173K
Net cash flow
Beginning cash position
-84.52%1.62M
-71.43%3.15M
-63.45%11.01M
-80.03%3.68M
-70.70%6.47M
-60.28%10.47M
-63.45%11.01M
89.49%30.12M
-48.43%18.43M
-45.81%22.07M
Current changes in cash
90.28%-387K
-198.45%-1.54M
59.38%-7.77M
89.80%-793K
25.10%-2.48M
11.30%-3.98M
85.50%-517K
-234.54%-19.14M
-38.54%-7.78M
34.11%-3.31M
Effect of exchange rate changes
119.05%4K
181.82%18K
-442.31%-89K
-111.80%-42K
97.92%-7K
-110.29%-21K
88.83%-22K
2,700.00%26K
17,700.00%356K
-1,785.00%-337K
Cash adjustments other than cash changes
---547K
----
----
----
---301K
--0
----
----
----
--0
End cash Position
-89.33%690K
-84.52%1.62M
-71.43%3.15M
-71.43%3.15M
-80.03%3.68M
-70.70%6.47M
-60.28%10.47M
-63.45%11.01M
-63.45%11.01M
-48.43%18.43M
Free cash from
80.14%-733K
59.73%-1.75M
20.66%-11.54M
71.00%-1.12M
31.17%-2.38M
6.27%-3.69M
-32.73%-4.34M
27.25%-14.54M
28.71%-3.88M
27.62%-3.46M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 80.10%-733K54.20%-1.75M21.22%-10.92M74.16%-1.07M28.15%-2.35M-8.10%-3.68M-24.93%-3.82M23.95%-13.86M18.59%-4.13M22.43%-3.27M
Net income from continuing operations 53.19%-1.69M50.57%-2.36M12.05%-13.03M48.51%-2.42M44.03%-2.23M-14.38%-3.6M-60.66%-4.77M-141.27%-14.81M9.41%-4.71M-203.83%-3.99M
Operating gains losses -----575.00%-135K99.39%-23K--096.71%-5K100.12%2K98.94%-20K77.52%-3.76M96.25%-45K98.44%-152K
Depreciation and amortization -20.50%353K-22.12%352K-30.80%1.83M-22.75%377K20.26%558K-45.52%444K-48.58%452K-17.11%2.65M-40.63%488K-45.02%464K
Asset impairment expenditure --0--0--19K--0--0--0--19K--0--0--0
Remuneration paid in stock -32.05%106K-70.08%158K-71.25%420K-59.20%82K-194.79%-346K-61.58%156K7.98%528K-14.21%1.46M-61.93%201K-26.41%365K
Deferred tax -----------15K------------------0--------
Other non cashItems 95.00%39K223.08%42K-82.24%84K828.57%65K-109.92%-13K-93.90%20K85.71%13K1,651.85%473K-12.50%7K1,771.43%131K
Change In working capital 165.05%456K568.29%192K-260.47%-207K1,330.43%849K-234.04%-314K-456.35%-701K-109.81%-41K140.82%129K-215.00%-69K-129.65%-94K
-Change in receivables --135K110.59%18K-----------------2,733.33%-170K------------
-Change in inventory --92K-97.06%1K----------------88.89%34K------------
-Change in prepaid assets --57K-20.25%256K----------------9.93%321K------------
-Change in payables and accrued expense --170K29.20%-160K-----------------22,700.00%-226K------------
-Change in other working capital --2K--77K--------------------------------
Cash from discontinued investing activities
Operating cash flow 80.10%-733K54.20%-1.75M21.22%-10.92M74.16%-1.07M28.15%-2.35M-8.10%-3.68M-24.93%-3.82M23.95%-13.86M18.59%-4.13M22.43%-3.27M
Investing cash flow
Cash flow from continuing investing activities 0-96.12%135K176.10%3.47M100.17%6K-110.45%-14K99.89%-1K1,159.76%3.48M-171.98%-4.55M-1,033.11%-3.46M120.68%134K
Capital expenditure reported ------09.24%-619K-123.20%-58K83.96%-30K-------524K61.38%-682K167.75%250K66.67%-187K
Net PPE purchase and sale --0--135K-94.31%7K-91.25%7K--0---7K--03.36%123K--80K--43K
Net investment purchase and sale --0--0199.50%4M99.50%-20K--21K--1K--4M---4.02M---4.02M--0
Net other investing changes --------196.15%77K-----101.80%-5K101.34%5K----196.30%26K265.63%234K419.54%278K
Cash from discontinued investing activities
Investing cash flow --0-96.12%135K176.10%3.47M100.17%6K-110.45%-14K99.89%-1K1,159.76%3.48M-171.98%-4.55M-1,033.11%-3.46M120.68%134K
Financing cash flow
Cash flow from continuing financing activities 216.89%346K140.80%71K56.02%-318K238.34%267K33.53%-115K-67.23%-296K3.33%-174K-102.12%-723K19.25%-193K-8.81%-173K
Net issuance payments of debt 13.79%-200K-13.79%-198K70.68%-212K413.92%609K-139.88%-415K-33.33%-232K4.40%-174K-13.50%-723K-18.29%-194K-4.85%-173K
Net common stock issuance --0--270K--------------0--0------------
Net other financing activities 953.13%546K---1K---106K---342K--300K-2,033.33%-64K----------------
Cash from discontinued financing activities
Financing cash flow 216.89%346K140.80%71K56.02%-318K238.34%267K33.53%-115K-67.23%-296K3.33%-174K-102.12%-723K19.25%-193K-8.81%-173K
Net cash flow
Beginning cash position -84.52%1.62M-71.43%3.15M-63.45%11.01M-80.03%3.68M-70.70%6.47M-60.28%10.47M-63.45%11.01M89.49%30.12M-48.43%18.43M-45.81%22.07M
Current changes in cash 90.28%-387K-198.45%-1.54M59.38%-7.77M89.80%-793K25.10%-2.48M11.30%-3.98M85.50%-517K-234.54%-19.14M-38.54%-7.78M34.11%-3.31M
Effect of exchange rate changes 119.05%4K181.82%18K-442.31%-89K-111.80%-42K97.92%-7K-110.29%-21K88.83%-22K2,700.00%26K17,700.00%356K-1,785.00%-337K
Cash adjustments other than cash changes ---547K---------------301K--0--------------0
End cash Position -89.33%690K-84.52%1.62M-71.43%3.15M-71.43%3.15M-80.03%3.68M-70.70%6.47M-60.28%10.47M-63.45%11.01M-63.45%11.01M-48.43%18.43M
Free cash from 80.14%-733K59.73%-1.75M20.66%-11.54M71.00%-1.12M31.17%-2.38M6.27%-3.69M-32.73%-4.34M27.25%-14.54M28.71%-3.88M27.62%-3.46M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg